Literature DB >> 6632731

[Does febrile proteinuria exist?].

W H Boesken, A Mamier, H Neumann, R Engelhardt.   

Abstract

The significance of proteinuria during febrile infectious diseases is widely underestimated, although the more marked proteinuria probably signalizes a parainfectious nephropathy rather than a functional disorder. This study shows that mild proteinuria of less than 0.65 g/24 h (normal range less than 0.3 g/24 h using the sensitive tannine-FeCl3-technique) might be caused by the elevated body temperature alone. 9 out of 18 volunteers without renal disease undergoing experimental hyperthermia of 40-41 degrees C for 1-2 h did not develop a proteinuria according to quantitative and qualitative (SDS-PAGE) measurements. In 6/18 the amount and composition of urinary proteins changed giving a glomerular type of proteinuria, possibly caused by temperature related transient glomerular alterations. In 3/18 a mild glomerulopathy existed before hyperthermia, as deduced from a glomerular pattern despite a quantitatively physiological proteinuria, leading in all 3 to pathological proteinuria during hyperthermia. In all 18 volunteers alterations reversed to normal within 12 h. Therefore, the degree of proteinuria during febrile diseases should be considered. Proteinuria of less than 0.5-1 g/24 h in adults might be explained by an altered glomerular function alone. Proteinurias exceeding this value, with a slow regressing tendency will indicate glomerular or tubulo-interstitial diseases, caused possibly by immunologic or toxic products resulting from underlying infectious disease.

Entities:  

Mesh:

Year:  1983        PMID: 6632731     DOI: 10.1007/BF01537532

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Laboratory aspects of proteinuria in human disease.

Authors:  J Hardwicke
Journal:  Clin Nephrol       Date:  1975-02       Impact factor: 0.975

2.  [Changes in clinical and immunological laboratory parameters of healthy adults after exposure to a one-hour 40 degree C-whole-body hyperthermia (author's transl)].

Authors:  H A Fabricius; H Neumann; R Stahn; R Engelhardt; G W Löhr
Journal:  Klin Wochenschr       Date:  1978-11-01

3.  Proteinuria in non-renal infectious diseases.

Authors:  H Jensen; K Henriksen
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

4.  Differentiation of proteinuric diseases by discelectrophoretic molecular weight analysis of urinary proteins.

Authors:  W H Boesken; K Kopf; P Schollmeyer
Journal:  Clin Nephrol       Date:  1973 Sep-Oct       Impact factor: 0.975

5.  Proteinuria in children with febrile illnesses.

Authors:  M I Marks; P N McLaine; K N Drummond
Journal:  Arch Dis Child       Date:  1970-04       Impact factor: 3.791

6.  [Proteins in the urine. 4. Characterization of proteinuria and indications for urinary protein analysis].

Authors:  B G Johansson; G Lindstedt
Journal:  Lakartidningen       Date:  1970-12-02

7.  Symposium on proteinuria and renal protein catabolism. Introduction.

Authors:  J W Boylan
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

8.  New colorimetric method for quantitative determination of protein in urine.

Authors:  H Yatzidis
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

9.  Quantitative immunological determination of 12 plasma proteins excreted in human urine collected before and after exercise.

Authors:  J Poortmans; R W Jeanloz
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

10.  On the mechanism of angiotensin-induced proteinuria. I. Studies in aminonucleoside nephrotic rats and in saralasin blockade.

Authors:  J W Bauman
Journal:  Nephron       Date:  1981       Impact factor: 2.847

View more
  1 in total

1.  The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa.

Authors:  Nikolai C Hodel; Ali Hamad; Claudia Praehauser; Grace Mwangoka; Irene Mndala Kasella; Klaus Reither; Salim Abdulla; Christoph F R Hatz; Michael Mayr
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.